Griffiths Richard Ian bought SLN
June 30, 2026 · Form 4 insider transaction
Griffiths Richard Ian bought 169,928 shares of Silence Therapeutics plc, a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
169,928
Price
N/A
Total value
N/A
InsiderGriffiths Richard Ian
Role—
SecurityAmerican Depositary Shares
Transaction codeS: Open-market sale
Transaction dateJune 30, 2026
Filing dateJuly 7, 2026
Shares owned after11,325,860
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.; The securities were sold by Cream Capital Limited ("CCL") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.